Aging
Navigate
Research Paper|Volume 9, Issue 1|pp 133—141

Association of neovascular age-related macular degeneration with month and season of birth in Italy

Antonio Longo1, Alessandra Casuccio2, Luca Pani3, Teresio Avitabile1, Salvatore Cillino4, Maurizio G. Uva1, Vincenza Bonfiglio1, Andrea Russo1, Guglielmo Parisi1, Gilda Cennamo5, Claudio Furino6, Mariacristina Parravano7, Entela Xoxi3, Michele Reibaldi1
  • 1Azienda Policlinico-Vittorio Emanuele, Catania, Italy
  • 2Departments of Sciences for Health Promotion and Mother Child Care, University of Palermo, Palermo, Italy
  • 3Italian Medicines Agency, Rome, Italy
  • 4Eye Clinic, University of Palermo, Palermo, Italy
  • 5Eye Clinic, University of Naples Federico II, Naples, Italy
  • 6Eye Clinic, University of Bari, Bari, Italy
  • 7Fondazione G.B. Bietti, IRCCS, Rome, Italy
Received: October 20, 2016Accepted: December 2, 2016Published: December 19, 2016

Copyright: © 2016 Longo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

In order to investigate the influence of season and month of birth on the risk of neovascular age-related macular degeneration (n-AMD) in Italy, we evaluated the month birth and sex of all patients, recorded in the anti-vascular endothelial growth factor (VEGF) monitoring registry of the Italian Medicines Agency, born between 1925–1944, who received intravitreal anti-VEGF injections for n-AMD between January 1, 2013 and July 29, 2015. The numbers of all births in Italy in the same years, extracted from the Italian National Institute of Statistics, were used to calculate the expected number of n-AMD cases. Overall, 45,845 patients (19,207 men, 26,638 women) received intravitreal anti-VEGF for n-AMD; in the same years, 20,140,426 people (10,334,262 male, 9,806,164 female) were born in Italy. Comparing the observed number of n-AMD cases with the expected number of n- AMD cases in each season, we found that the season-specific risk for n-AMD was 2.5% higher for those born in summer (OR=1.03, Bonferroni-corrected P=0.008) and 3% lower for those born in winter (OR=0.96, Bonferroni-corrected P=0.0004). When considering the month of birth, the risk of n-AMD was 5.9% lower for people born in January (OR=0.93, Bonferroni-corrected P=0.0012). The factors causing such differences should be determined.